L. Stern

机构：Cedars-Sinai Medical Center, BridgeBio (United States), Cedars-Sinai Smidt Heart Institute, Bridge Pharma (United States), Columbia University · ORCID：0000-0003-3024-9563

发表论文 99 篇 · 总被引 355 次 · h-index 10

代表论文

• Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy (2025 · JAMA Cardiology · 被引 5)
• Clinical Characteristics and Outcomes Associated With Immediate Versus Delayed Presentation of Severe Primary Graft Dysfunction After Heart Transplantation: Does Timing Matter? (2025 · Clinical Transplantation · 被引 3)
• Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy (2026 · JAMA Cardiology · 被引 1)
• Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CM (2026 · Future Cardiology · 被引 1)
• The efficacy of biodegradable polymer everolimus-eluting stents in patients with cardiac allograft vasculopathy (2025 · JHLT Open · 被引 1)
• International Validation of Echocardiographic Artificial Intelligence Amyloid Detection Algorithm (2025 · JACC Advances · 被引 1)